ACHE and Alzheimer disease: Currently available medication for the treatment of AD including AChE inhibitors and N-methyl-D-aspartate (NMDA) receptor antagonist can only improve the functions of intact neurons but cannot inhibit the ongoing neurodegenerative process leading to neuronal death [27].